Viewing StudyNCT00514267



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00514267
Status: COMPLETED
Last Update Posted: 2015-08-13
First Post: 2007-08-07

Brief Title: An Open-Label Study of YM155 Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Tumors
Keywords:
Name View
Prostate Cancer View
HRPC View
Hormone Refractory Prostate Cancer View
YM155 View
Treatment Outcome View
Solid Tumors View